205 related articles for article (PubMed ID: 33096309)
21. Hybrid benzothiazole analogs as antiurease agent: Synthesis and molecular docking studies.
Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Khan KM; Riaz M
Bioorg Chem; 2016 Jun; 66():80-7. PubMed ID: 27038849
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and molecular docking study of some novel 2,3-disubstituted quinazolin-4(3H)-one derivatives as potent inhibitors of urease.
Akyüz G; Menteşe E; Emirik M; Baltaş N
Bioorg Chem; 2018 Oct; 80():121-128. PubMed ID: 29894891
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.
Xiao ZP; Peng ZY; Dong JJ; He J; Ouyang H; Feng YT; Lu CL; Lin WQ; Wang JX; Xiang YP; Zhu HL
Eur J Med Chem; 2013 May; 63():685-95. PubMed ID: 23567958
[TBL] [Abstract][Full Text] [Related]
24. Design, molecular docking and synthesis of novel 5,6-dichloro-2-methyl-1H-benzimidazole derivatives as potential urease enzyme inhibitors.
Menteşe E; Emirik M; Sökmen BB
Bioorg Chem; 2019 May; 86():151-158. PubMed ID: 30710848
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of novel series of aminopyrimidine derivatives as urease inhibitors and antimicrobial agents.
Adsul LK; Bandgar BP; Chavan HV; Jalde SS; Dhakane VD; Shirfule AL
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1316-23. PubMed ID: 23230954
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, in vitro urease inhibitory potential and molecular docking study of benzofuran-based-thiazoldinone analogues.
Taha M; Rahim F; Ullah H; Wadood A; Farooq RK; Shah SAA; Nawaz M; Zakaria ZA
Sci Rep; 2020 Jun; 10(1):10673. PubMed ID: 32606439
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of 4-thiazolidinone analogs as potent in vitro anti-urease agents.
Rahim F; Zaman K; Ullah H; Taha M; Wadood A; Javed MT; Rehman W; Ashraf M; Uddin R; Uddin I; Asghar H; Khan AA; Khan KM
Bioorg Chem; 2015 Dec; 63():123-31. PubMed ID: 26520885
[TBL] [Abstract][Full Text] [Related]
28. Utility of anthranilic acid and diethylacetylenedicarboxylate for the synthesis of nitrogenous organo/organometallic compounds as urease inhibitors.
El-Zahabi HSA; Abdulwahab HG; Edrees MM; Hegab AM
Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800314. PubMed ID: 31210387
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of new arylhydrazide bearing Schiff bases/thiazolidinone: α-Amylase, urease activities and their molecular docking studies.
Rahim F; Taha M; Ullah H; Wadood A; Selvaraj M; Rab A; Sajid M; Shah SAA; Uddin N; Gollapalli M
Bioorg Chem; 2019 Oct; 91():103112. PubMed ID: 31349115
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and molecular docking study of piperazine derivatives as potent urease inhibitors.
Taha M; Wadood A
Bioorg Chem; 2018 Aug; 78():411-417. PubMed ID: 29689419
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, in vitro and in silico studies of novel potent urease inhibitors: N-[4-({5-[(3-Un/substituted-anilino-3-oxopropyl)sulfanyl]-1,3,4-oxadiazol-2-yl}methyl)-1,3-thiazol-2-yl]benzamides.
Abbasi MA; Hassan M; Aziz-Ur-Rehman ; Siddiqui SZ; Raza H; Shah SAA; Seo SY
Bioorg Med Chem; 2018 Jul; 26(13):3791-3804. PubMed ID: 29903414
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, enzyme inhibitory kinetics, and computational studies of novel 1-(2-(4-isobutylphenyl) propanoyl)-3-arylthioureas as Jack bean urease inhibitors.
Abdul Fattah T; Saeed A; Channar PA; Ashraf Z; Abbas Q; Hassan M; Larik FA
Chem Biol Drug Des; 2018 Feb; 91(2):434-447. PubMed ID: 28834266
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, in vitro evaluation, molecular docking and ADME properties studies of hybrid bis-coumarin with thiadiazole as a new inhibitor of Urease.
Alomari M; Taha M; Imran S; Jamil W; Selvaraj M; Uddin N; Rahim F
Bioorg Chem; 2019 Nov; 92():103235. PubMed ID: 31494327
[TBL] [Abstract][Full Text] [Related]
34. Investigation on the effect of alkyl chain linked mono-thioureas as Jack bean urease inhibitors, SAR, pharmacokinetics ADMET parameters and molecular docking studies.
Larik FA; Faisal M; Saeed A; Channar PA; Korabecny J; Jabeen F; Mahar IA; Kazi MA; Abbas Q; Murtaza G; Khan GS; Hassan M; Seo SY
Bioorg Chem; 2019 May; 86():473-481. PubMed ID: 30772648
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, X-ray molecular structure, biological evaluation and molecular docking studies of some N
Pervez H; Khan N; Zaib S; Yaqub M; Naseer MM; Tahir MN; Iqbal J
Bioorg Med Chem; 2017 Feb; 25(3):1022-1029. PubMed ID: 28011200
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and Studies of Fluorescein Based Derivatives for their Optical Properties, Urease Inhibition and Molecular Docking.
Mahajan PG; Dige NC; Vanjare BD; Raza H; Hassan M; Seo SY; Hong SK; Lee KH
J Fluoresc; 2018 Nov; 28(6):1305-1315. PubMed ID: 30220013
[TBL] [Abstract][Full Text] [Related]
37. Design, Synthesis, Photophysical Properties, Biological Estimation and Molecular Docking Studies of Novel Schiff Base Derivatives as Potential Urease Inhibitors.
Vanjare BD; Mahajan PG; Hassan M; Raza H; Seo SY; Hong SK; Lee KH
J Fluoresc; 2018 Nov; 28(6):1295-1304. PubMed ID: 30215145
[TBL] [Abstract][Full Text] [Related]
38. Discovery of indole-based tetraarylimidazoles as potent inhibitors of urease with low antilipoxygenase activity.
Naureen S; Chaudhry F; Asif N; Munawar MA; Ashraf M; Nasim FH; Arshad H; Khan MA
Eur J Med Chem; 2015 Sep; 102():464-70. PubMed ID: 26310891
[TBL] [Abstract][Full Text] [Related]
39. Synthetic nicotinic/isonicotinic thiosemicarbazides: In vitro urease inhibitory activities and molecular docking studies.
Ali B; Mohammed Khan K; Arshia ; Kanwal ; Hussain S; Hussain S; Ashraf M; Riaz M; Wadood A; Perveen S
Bioorg Chem; 2018 Sep; 79():34-45. PubMed ID: 29723741
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, Antioxidant and In-Silico Studies of Potent Urease Inhibitors: N-(4-{[(4-Methoxyphenethyl)-(substituted)amino]sulfonyl}phenyl)acetamides.
Abbasi MA; Raza H; Rehman AU; Siddiqui SZ; Nazir M; Mumtaz A; Shah SAA; Seo SY; Hassan M
Drug Res (Stuttg); 2019 Feb; 69(2):111-120. PubMed ID: 30086567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
